StockData

Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.43+0.12 (+3.63%)

Close on Nov 18, 2026Market cap $31.84MP/E –Yield –

Exozymes revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2023 it was $70.07K.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$70.07K–

More Exozymes figures

See a number that looks wrong?